ABIRIBA

Welcome to the Brand page for “ABIRIBA”, which is offered here for Human pharmaceuticals for the prevention or treatment of cardiovascular diseases, metabolism diseases, auto-immune diseases, infectious diseases, central nervous system diseases, and oncological diseases; vaccines;.

Its status is currently believed to be active. Its class is unavailable. “ABIRIBA” is believed to be currently owned by “Johnson & Johnson”.


Owner:
JOHNSON & JOHNSON
Owner Details
Description:
Human pharmaceuticals for the prevention or treatment of cardiovascular diseases, metabolism diseases, auto-immune diseases, infectious diseases, central nervous system diseases, and oncological diseases; vaccines;
Categories: HUMAN PHARMACEUTICALS PREVENTION